AMWL.NYSEAmerican Well CORP
10-K: American Well Corporation Reports Fiscal Year 2024 Results, Focuses on Platform Growth and Cost Efficiency
Sentiment:
Annual Results
American Well Corporation's 2024 10-K filing reveals a company in transition, focusing on its Converge platform and strategic partnerships while navigating losses and market volatility.
Capital raiseThe company may need to engage in equity or debt financings or collaborative arrangements to secure additional funds.If the company raises additional funds through further issuances of equity or convertible debt securities, existing stockholders could suffer significant dilution.
Worse than expectedRevenue decreased from 2023 to 2024.The company continues to operate at a loss.
Summary
- American Well Corporation's 10-K filing reports on the fiscal year ended December 31, 2024.
- The company is focused on digitally enabling hybrid care through its enterprise platform and software solutions.
- Amwell powers digital care programs for approximately 50 health plans, covering over 80 million lives, and around 100 of the largest health systems.
- Since its inception, Amwell has facilitated over 33.1 million virtual care visits, with 5.9 million occurring in 2024.
- A key strategy for 2025 involves migrating health plan and health system clients to the Amwell Converge platform.
- The company sold its telepsychiatry business, Aligned Telehealth, for $20.7 million upfront plus a potential additional payment based on future revenue.
- The company estimates its total addressable market (TAM) in the U.S. at approximately $94 billion, with a hybrid care platform TAM of roughly $31 billion, projected to grow to $50 billion in four years.
- For the year ended December 31, 2024, Elevance accounted for 27% of Amwell's revenue.
- The company incurred a net loss of $212.6 million for the year ended December 31, 2024, and had an accumulated deficit of $1,965.9 million.
- As of December 31, 2024, Amwell had $228.3 million in cash, cash equivalents, and short-term investments.
- The company has approximately $986.0 million of federal net operating loss carryforwards as of December 31, 2024.
- The company is subject to various healthcare regulations, including those related to digital care provider licensing, corporate practice of medicine, and data privacy.
- The company's Board consists of nine directors, 22% of whom are women and 78% of whom are independent.
Sentiment
Score: 5
Explanation: The document presents a mixed picture. While Amwell is making strategic moves to focus on its core platform and improve efficiency, it continues to face challenges related to profitability, competition, and market volatility. The outlook is cautiously optimistic, but significant risks remain.
Positives
- High patient satisfaction with the platform, indicated by a 90% 'thumbs-up' rating.
- Focus on the Amwell Converge platform, which is designed to be future-ready and scalable.
- Strategic partnerships with major health systems and health plans.
- Expansion of the Carepoint suite of devices to enhance in-person care.
- Experienced management team with extensive operational experience.
- Commitment to ESG initiatives and corporate social responsibility.
- The company has a strong focus on innovation and interoperability.
Negatives
- History of net losses and accumulated deficit.
- Reliance on a limited number of clients for a substantial portion of revenue.
- The digital care market is still developing and volatile.
- Increased competition from existing and potential new participants in the healthcare industry.
- The company may need additional capital to support the growth of its business.
- The company may be subject to medical liability claims.
Risks
- Weak growth and increased volatility in the digital care market.
- Inability to adapt to rapid technological changes.
- Increased competition from existing and potential new participants in the healthcare industry.
- Changes in healthcare laws, regulations or trends.
- Slower than expected growth in patient adoption of digital care.
- Inability to grow the base of affiliated and non-affiliated providers.
- Cybersecurity breaches and failure to comply with privacy regulations.
- The impact of seasonal viruses on the business.
- The continuation of the Defense Health Agency relationship beyond July of 2025 with comparable financial terms.
Future Outlook
The company's future growth, success and performance are dependent on many factors, including digital care utilization, investments in growth, acquisitions, and seasonality. The company expects to continue to focus on long-term revenue growth through investments in technology development and sales and marketing efforts. The company expects to generate operating losses in future years.
Industry Context
The announcement reflects the ongoing shift towards digital and hybrid care models in the healthcare industry, with companies like Amwell positioning themselves as key enablers of this transition. The competitive landscape includes traditional telehealth players, technology giants, and EHR providers, all vying for a share of the growing digital care market.
Comparison to Industry Standards
- Teladoc Health is a primary competitor in the telehealth platform space; comparing their growth, profitability, and platform adoption rates would provide valuable context.
- Zoom and Microsoft Teams are technology players expanding into healthcare; assessing Amwell's ability to differentiate its platform with healthcare-specific features is crucial.
- Epic and Oracle Health (Cerner) are EHR providers that also offer telehealth solutions; Amwell's partnerships and integrations with these players are vital for its success.
- Care.AI and Avasure are virtual nursing offerings; comparing Amwell's Carepoint devices and virtual nursing solutions to these competitors is important.
- Digital behavioral health companies like Ableto and Headspace compete with Amwell's SilverCloud offering; evaluating market share and growth in this segment is relevant.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Kathy Weiler | Mark Hirschhorn | October 14, 2024 | Not specified |
| Director | Roy Schoenberg | Roy Schoenberg | June 13, 2024 | Transition Agreement |
Related Party Transactions
- The company has related-party transactions with Cleveland Clinic and CCAW, JV LLC, a joint venture with Cleveland Clinic.
Stakeholder Impact
- Shareholders face potential dilution from future equity financings.
- Employees may be affected by cost-reduction efforts, including headcount reductions.
- Customers (health plans and health systems) can expect continued platform enhancements and new solutions.
- Suppliers and creditors may be impacted by the company's financial performance and ability to meet obligations.
Next Steps
- Continue migration of health plan and health system clients onto the Amwell Converge platform.
- Invest in platform to continue to expand capabilities.
- Selectively pursue acquisitions.
- Drive greater adoption with existing clients.
Key Dates
| Date | Description |
|---|---|
| 2006 | Amwell was founded. |
| 1996 | The Health Insurance Portability and Accountability Act of 1996 (HIPAA) was enacted. |
| 2012 | Amwell entered into a joint venture with an affiliate of Elevance Health, Inc. to form National Telehealth Network, LLC (NTN). |
| January 1, 2016 | The Company made an additional investment in NTN, which increased its ownership percentage above 50 %. |
| August 1, 2017 | Amendment No. 6 to the Business Support Agreement, dated August 1, 2017, by and among National Telehealth Network, LLC and Online Care Network P.C. |
| August 1, 2017 | Amendment No. 4 to the Business Support Subcontractor Services Agreement, dated August 1, 2017, by and among National Telehealth Network, LLC and American Well Corporation |
| June 18, 2020 | Employment Agreement between American Well Corporation and Ido Schoenberg, dated June 18, 2020 |
| June 18, 2020 | Restricted Stock Unit Agreement between American Well Corporation and Ido Schoenberg, dated June 18, 2020 |
| June 18, 2020 | Restricted Stock Unit Agreement between American Well Corporation and Roy Schoenberg, dated June 18, 2020 |
| August 26, 2020 | Employment Agreement between American Well Corporation and Kurt Knight, dated August 26, 2020 |
| September 4, 2020 | American Well Corporation Statement of Policy Concerning Trading in Company Securities Originally Adopted September 4, 2020 |
| September 14, 2020 | The Company received a letter from Teladoc Health, Inc. alleging that certain of the Company’s cart products and associated peripherals infringe upon their patents. |
| September 21, 2020 | The Company closed on the initial public offering raising $ 822,267 in gross proceeds. |
| September 21, 2020 | The Company closed on a private placement with Google raising $ 100,000 in gross proceeds. |
| October 12, 2020 | Teladoc Health, Inc filed a claim against the Company related to these allegations. |
| January 1, 2023 | Master Services Agreement, dated January 1, 2023, by and among American Well Corporation and Elevance Health, Inc. |
| November 28, 2022 | Statement of Work, dated as of November 28, 2022, by and between American Well Corporation and Elevance Health, Inc. |
| November 28, 2022 | Provider Agreement, dated as of November 28, 2022, by and between Blue Cross of California doing business as Anthem Blue Cross and Online Care Group, P.C. |
| November 28, 2022 | Provider Agreement, dated as of November 28, 2022, by and among Rocky Mountain Hospital and Medical Service, Inc., doing business as Anthem Blue Cross and Blue Shield and HMO Colorado, Inc. doing business as HMO Colorado, Anthem Health Plans, Inc. doing business as Anthem Blue Cross and Blue Shield, Anthem Insurance Companies, Inc. doing business as Anthem Blue Cross and Blue Shield, Anthem Health Plans of Kentucky, Inc. d/b/a Anthem Blue Cross and Blue Shield, Anthem Health Plans of Maine, Inc. doing business as Anthem Blue Cross and Blue Shield, RightCHOICE Managed Care, Inc., Anthem Health Plans of New Hampshire, Inc. doing business as Anthem Blue Cross and Blue Shield and Matthew Thornton Health Plan, Inc., Rocky Mountain Hospital and Medical Service, Inc. doing business as Anthem Blue Cross and Blue Shield and HMO Colorado, Inc. doing business as HMO Nevada, Empire Health Choice HMO, Inc. (d/b/a Empire BlueCross BlueShield HMO or Empire Blue Cross HMO) and Empire Health Choice Assurance, Inc. (d/b/a Empire BlueCross BlueShield or Empire Blue Cross), Community Insurance Company doing business as Anthem Blue Cross and Blue Shield, Anthem Health Plans of Virginia, Inc. doing business as Anthem Blue Cross and Blue Shield, Blue Cross Blue Shield of Wisconsin doing business as Anthem Blue Cross and Blue Shield and Online Care Group, P.C. |
| June 30, 2022 | The claim was dismissed pursuant to a confidential settlement between the parties. |
| August 22, 2024 | Amendment to Employment Agreement between American Well Corporation and Kathy Weiler, dated August 16, 2024 |
| October 15, 2024 | Employment Agreement between American Well Corporation and Mark Hirschhorn, dated October 14, 2024 |
| December 18, 2024 | Separation Agreement between American Well Corporation and Kathy Weiler, dated December 17, 2024 |
| January 8, 2025 | Amwell entered into an asset purchase agreement relating to the sale of all property and assets owned, leased or licensed by Amwell's wholly owned subsidiary, Aligned Telehealth, LLC |
| March 31, 2025 | Most of the federal waivers have been extended through March 31, 2025. |
| July 2025 | The continuation of the Defense Health Agency relationship beyond July of 2025 with comparable financial terms. |
Keywords
digital care, telehealth, hybrid care, virtual care, Amwell, Converge platform, health plans, health systems, AMG, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.